Younger People Are Aging Faster Than Previous Generations
- A new study published in Nature finds that younger adults—particularly millennials and Gen Z—are exhibiting accelerated biological aging compared to previous generations, a trend researchers link to rising...
- "We’re seeing a 10–15% increase in early-onset cancer diagnoses in millennials and Gen Z compared to Gen X at the same age," said lead author Dr.
- The study authors propose several potential drivers, all requiring further investigation.
A new study published in Nature finds that younger adults—particularly millennials and Gen Z—are exhibiting accelerated biological aging compared to previous generations, a trend researchers link to rising rates of early-onset cancer and other age-related diseases. The findings, based on epigenetic clock analysis of tissue samples from over 100,000 participants, suggest that by age 30, members of these generations show biological markers equivalent to those of people in their late 40s or early 50s from prior cohorts.
"We’re seeing a 10–15% increase in early-onset cancer diagnoses in millennials and Gen Z compared to Gen X at the same age," said lead author Dr. Tony Ky, though he emphasized that the study does not prove causation. The data aligns with earlier reports from ScienceAlert and Euronews, which highlighted similar trends in accelerated aging metrics like telomere shortening and DNA methylation patterns.

Why are younger people aging faster?
The study authors propose several potential drivers, all requiring further investigation. Environmental factors top the list: higher exposure to pollutants, chronic stress from economic instability, and lifestyle changes such as poor sleep, sedentary behavior, and diets high in processed foods. “The modern environment is a moving target,” said Ky. “We’re not just talking about genetics—it’s the cumulative impact of how we live.”
Yet the biological mechanisms remain unclear. While the Nature study controls for known risk factors like smoking and alcohol use, it does not account for emerging variables such as gut microbiome shifts or exposure to endocrine-disrupting chemicals in consumer products.
What does this mean for early-onset cancer risks?
The rise in early-onset cancers is one of the most immediate public health concerns. Data from the American Cancer Society show that between 2010 and 2020, cases of colorectal cancer in adults under 50 more than doubled, while breast cancer diagnoses in women under 40 increased significantly. The Nature study estimates that by 2030, a substantial proportion of cancer diagnoses in the U.S. could occur in people under 50—a reversal of the decades-long trend of declining early-onset rates.
Screening guidelines are already adapting. The U.S. Preventive Services Task Force lowered the recommended colorectal cancer screening age from 50 to 45 in 2021.
How do experts interpret the findings?
Reactions from the scientific community vary. Dr. S. Glenn Laboratories for the Biology of Aging at Harvard Medical School, called the Nature study "a critical wake-up call" but urged caution. "We can’t assume these trends will continue," he said. "Some of this may be reversible with targeted interventions—better sleep hygiene, reduced screen time, or even specific supplements like NAD+ boosters, though those need rigorous testing."
"Correlation isn’t causation," she said. "We need to rule out confounding factors like improved diagnosis or reporting biases before blaming lifestyle alone." Her lab’s work on C. elegans (a model organism) suggests that some aging acceleration may stem from epigenetic reprogramming triggered by early-life environmental exposures.
What’s next for research?
The Nature study’s authors are launching a follow-up investigation to track participants over a decade, with a focus on three areas:

- Environmental exposures: Measuring air quality, water contaminants, and workplace hazards in participants’ daily lives.
- Gut microbiome links: Analyzing how shifts in gut bacteria—linked to processed food consumption—may accelerate aging.
- Pharmacological interventions: Testing whether existing drugs like metformin (a diabetes medication) or rapamycin (an immunosuppressant) can slow epigenetic aging in high-risk groups.
Meanwhile, public health agencies are debating whether to expand screening programs. The World Health Organization’s International Agency for Research on Cancer (IARC) is reviewing evidence on early-onset cancer clusters, with a preliminary report expected in 2027.
For now, experts agree on one clear message: while the biological clock may be ticking faster for some, lifestyle changes can still make a difference. “This isn’t a death sentence,” said Ky. “It’s a call to action—one that starts with how we live today.”
